Non-Alcoholic Fatty Liver Disease Fibrosis Score Predicts Hematological Toxicity of Chemotherapy Including Irinotecan for Colorectal Cancer

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2017.1177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Current Modalities of Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Translational Hepatology
2017English

Clinical Impact of Non-Alcoholic Fatty Liver Disease on the Occurrence of Colorectal Neoplasm: Propensity Score Matching Analysis

PLoS ONE
Multidisciplinary
2017English

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2014English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Sarcopenia Is Associated With Severe Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Non-Alcoholic Fatty Liver Diseases and Risk of Colorectal Neoplasia

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy